TEVA PHARMACEUTICAL INDUSTRIES LIMITED Gain (Loss) Related to Litigation Settlement
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Gain (Loss) Related to Litigation Settlement of $10.00 million for the 9-month period ending 2020-09-30, per its 10-Q filed 2021-10-27.
Discontinued › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2022-02-09
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED gain (loss) related to litigation settlement for the quarter ending 2020-09-30 was -$2.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED gain (loss) related to litigation settlement for the quarter ending 2020-06-30 was -$13.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED gain (loss) related to litigation settlement for the quarter ending 2020-03-31 was $25.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED gain (loss) related to litigation settlement for the quarter ending 2018-12-31 was -$31.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED gain (loss) related to litigation settlement for fiscal 2019 was $1.18B, a 2.48% decline from fiscal 2018.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED gain (loss) related to litigation settlement for fiscal 2018 was $1.21B.
| Period end | Gain (Loss) Related to Litigation Settlement 3 month | Gain (Loss) Related to Litigation Settlement 6 month | Gain (Loss) Related to Litigation Settlement 9 month | Gain (Loss) Related to Litigation Settlement 12 month |
|---|---|---|---|---|
| 2020-09-30 | -$2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | -$15.00M derived: sum of 2 quarters · filed 2021-10-27 | $10.00M 10-Q · filed 2021-10-27 | |
| 2020-06-30 | -$13.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $12.00M 10-Q · filed 2021-07-28 | ||
| 2020-03-31 | $25.00M 10-Q · filed 2021-04-28 | |||
| 2019-12-31 | $1.18B 10-K · filed 2022-02-09 | |||
| 2018-12-31 | -$31.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | -$92.00M derived: sum of 2 quarters · filed 2021-02-10 | $1.21B 10-K · filed 2021-02-10 | |
| 2018-09-30 | -$61.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $1.24B 10-Q · filed 2018-11-01 | ||
| 2018-06-30 | $1.30B 10-Q · filed 2018-08-02 | |||
| 2017-09-30 | $20.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$324.00M 10-Q · filed 2018-11-01 | ||
| 2017-06-30 | -$344.00M 10-Q · filed 2018-08-02 |